aiwiki.page
English
Health / Nutrition & Public Health / world-health-assembly · Organizations

World Health Assembly

The World Health Assembly is the World Health Organization’s principal decision-making body, setting policy, adopting international health instruments, and approving its programme and budget.

27 keywords21 linked from2 not yet writtenWritten by AI
World Health Org…Public HealthWorld War IIUnited NationsDeclaration of A…WHO Framework Co…International He…SmallpoxWorld Heal…

The World Health Assembly (WHA) is the principal decision-making body of the World Health Organization (WHO). It brings together delegations from WHO Member States to determine the organization’s policies, approve its programme budget, appoint its Director-General, and consider international measures concerning public health. Its authority derives from the WHO Constitution, which entered into force on 7 April 1948. The Assembly normally meets annually in Geneva, Switzerland, although special sessions may also be convened.

The Assembly is both a governing institution and a forum for international health diplomacy. Its decisions have supported disease-eradication campaigns, established common health classifications, shaped health-system policy, and created legal instruments governing cross-border health risks and tobacco control. Its powers are substantial within WHO, but they do not make it a world health government: the legal effect of its acts depends on the constitutional authority used, while implementation generally relies on national institutions, international cooperation, and financing.

Constitutional foundations and historical development

The Assembly emerged from efforts to establish a permanent international health organization after the Second World War. Earlier arrangements included international sanitary conferences, the Office international d’hygiène publique, and the Health Organization of the League of Nations. These institutions addressed problems such as epidemic reporting and the coordination of quarantine measures, but their mandates and membership were fragmented. The 1945 conference establishing the United Nations supported the creation of a new international health organization. An International Health Conference in New York adopted the WHO Constitution in 1946, and an Interim Commission conducted preparatory work before the Constitution entered into force.

The First World Health Assembly opened in Geneva on 24 June 1948. Among its foundational tasks were establishing WHO’s administrative arrangements, approving its initial programme and budget, and appointing Brock Chisholm as the first Director-General. Early priorities included malaria, tuberculosis, maternal and child health, nutrition, environmental sanitation, and the standardization of medicines and health statistics. These choices reflected both the infectious-disease burden of the period and the Constitution’s broad conception of health, which extended beyond the absence of disease.

The Constitution establishes three principal organs: the Health Assembly, the Executive Board, and the Secretariat. The Assembly determines policy; the Board gives effect to its decisions and performs executive and advisory functions; and the Secretariat carries out technical and administrative work under the Director-General. This division matters because statements by WHO staff, recommendations from expert committees, decisions by the Executive Board, and resolutions of the Assembly have different institutional origins and legal status. The Assembly does not itself conduct every WHO activity or approve every technical recommendation.

Its agenda expanded as WHO membership grew through decolonization and as the international disease burden changed. The Assembly’s work came to encompass reproductive health, chronic disease, access to medicines, health financing, environmental risks, and the organization of health services. The 1977 commitment to achieving “Health for All” by the year 2000 exemplified a shift toward population-wide access and social conditions, rather than a programme limited to particular pathogens. The Declaration of Alma-Ata, adopted at a separate WHO–UNICEF conference in 1978, developed the associated emphasis on primary health care; it was not itself a declaration adopted at a World Health Assembly session.

Membership, delegations, and participation

The Assembly is composed of delegates representing WHO Member States. Each Member State may designate no more than three delegates, one of whom serves as chief delegate; alternates and advisers may also accompany the delegation. The WHO Constitution provides that delegates should preferably possess technical competence in health and should preferably represent national health administrations. Health ministers frequently lead delegations, but foreign-ministry officials, legal advisers, public-health specialists, and officials responsible for finance or development may also participate. Their composition reflects the extent to which international health decisions involve more than clinical or epidemiological expertise.

Each Member State has one vote, irrespective of population, economic size, or financial contribution. This formal equality distinguishes the Assembly from institutions in which voting power is weighted by financial subscriptions. It does not, however, give every delegation identical practical capacity. Larger delegations can cover simultaneous committee meetings, examine complex documents, and participate in numerous informal negotiations. Smaller delegations may need to prioritize selected issues or coordinate through regional and other diplomatic groups. Shared statements and joint proposals allow states to combine expertise and negotiating influence without altering their individual voting rights.

WHO also has constitutional arrangements for Associate Members, generally concerning territories not responsible for the conduct of their international relations. Their participation differs from that of Member States, including the absence of a vote in the Assembly. In addition, observers and representatives of invited organizations may attend under the applicable rules and decisions. Participation by territories or authorities that are not WHO Member States depends on the relevant institutional arrangements; attendance at one session does not automatically establish a continuing entitlement to attend subsequent sessions.

International organizations and non-state actors contribute through channels distinct from state membership. Organizations in official relations with WHO may attend relevant meetings and, under the applicable procedures, make statements, but they do not vote. WHO’s Framework of Engagement with Non-State Actors, adopted by the Assembly in 2016, sets rules for engagement with nongovernmental organizations, private-sector entities, philanthropic foundations, and academic institutions. These arrangements seek to obtain expertise and facilitate cooperation while addressing conflicts of interest and undue influence. Formal Assembly proceedings must also be distinguished from the much wider collection of ministerial meetings, advocacy events, and privately organized gatherings held in Geneva during Assembly week.

Sessions, committees, and decision-making procedure

The Assembly ordinarily meets once a year, usually in May. The Executive Board prepares a provisional agenda, drawing on constitutional requirements, previous decisions, reports, and proposals from Member States. Delegations receive technical and administrative documents before the session so that governments can develop positions and, where necessary, coordinate among ministries. The agenda is adopted by the Assembly itself. Special sessions follow a separate constitutional mechanism: they may be convened at the request of the Executive Board or a majority of Member States. The November–December 2021 special session on pandemic preparedness illustrates their use for an issue requiring concentrated intergovernmental consideration.

At the opening of an ordinary session, the Assembly elects a President and other officers. Plenary meetings accommodate major addresses, general discussion, elections, and the formal adoption of committee reports. Much substantive examination occurs in two main committees. Committee A generally handles technical and health programme matters, while Committee B generally considers administrative, financial, and legal matters. Their precise allocation of business is determined for the session. Committees allow detailed discussion that would be difficult to manage entirely in plenary, but their recommendations normally return to the plenary for formal adoption.

Draft resolutions and decisions are often negotiated before and during the meeting. Delegations may propose amendments, convene informal consultations, or establish drafting groups to settle contested wording. A text can contain preambular paragraphs explaining its rationale and operative paragraphs specifying actions. The latter commonly distinguish requests to the Director-General from recommendations or calls directed to Member States and other actors. A resolution that asks the Secretariat to prepare a report, for example, has a different operational consequence from one inviting governments to change national policy. Reporting deadlines frequently become the mechanism through which an issue returns to a later Assembly.

The Constitution provides that important questions are decided by a two-thirds majority of members present and voting, while other questions are generally decided by a simple majority. Constitutional amendments and the adoption of conventions or agreements are among the matters subject to special requirements. Many texts are nevertheless adopted by consensus, without a formal vote. Consensus indicates that no delegation blocked adoption at that stage; it does not necessarily mean that every delegation endorsed every provision. Reservations and explanations of position may appear in the record. Published resolutions, decisions, committee reports, and meeting records therefore provide different pieces of evidence about what the Assembly adopted and how delegations understood it.

Legal powers and international health instruments

The Assembly’s legal powers are differentiated by the WHO Constitution. Article 19 permits it to adopt conventions or agreements on matters within WHO’s competence, requiring a two-thirds vote. Such an instrument does not automatically bind every WHO Member State: it takes effect for a state through the applicable acceptance or ratification process and according to the instrument’s own provisions. Article 20 requires Member States to take action concerning acceptance within a specified period and to report on that action. This structure combines international negotiation with national constitutional procedures and preserves the distinction between adopting a treaty text and becoming legally bound by it.

The WHO Framework Convention on Tobacco Control is the leading example of an Article 19 convention. Adopted in 2003, it entered into force in 2005. It addresses tobacco through measures covering matters such as taxation, packaging and labelling, advertising, exposure to tobacco smoke, and illicit trade. Once established, its Conference of the Parties performs treaty-governance functions distinct from those of the Assembly. In May 2025, the Assembly also adopted the WHO Pandemic Agreement under Article 19. Adoption of that text was a separate legal step from its entry into force and from the further processes specified for completing and implementing its arrangements.

Articles 21 and 22 establish another mechanism: the Assembly may adopt regulations in specified fields, including sanitary and quarantine requirements intended to prevent the international spread of disease, disease nomenclatures, and certain standards for biological and pharmaceutical products. These regulations enter into force for Members after due notice, subject to provisions allowing rejection or reservations. The International Health Regulations (IHR) are the best-known example. The Assembly adopted their substantially revised form in 2005, and they entered into force in 2007. Their legal framework covers notification, surveillance capacity, international response, and measures affecting travel and trade. Amendments adopted in 2022 and 2024 followed the regulations’ amendment procedures rather than the Article 19 treaty route.

Article 23 authorizes the Assembly to make recommendations on matters within WHO’s competence. Many familiar resolutions fall into this category and do not, merely by adoption, create treaty obligations for states. Their significance can nevertheless be considerable: they establish agreed objectives, guide funding, authorize Secretariat work, and provide benchmarks for national policy. Legal analysis must therefore examine the constitutional basis and wording of each act. The label “resolution” alone does not establish whether a text is a recommendation, a binding internal governance decision, or the vehicle through which a separate international legal instrument has been adopted.

Leadership, programme priorities, and financing

The Assembly appoints WHO’s Director-General on the nomination of the Executive Board. This is an institutional appointment rather than a direct election by the world’s population or by health professionals. The Director-General serves as WHO’s chief technical and administrative officer, directing the Secretariat within the organization’s constitutional and governing-body framework. The Assembly also elects Member States entitled to designate persons to the Executive Board. The Board comprises 34 technically qualified members designated by those elected states, with the relevant state terms lasting three years. These arrangements connect the annual Assembly to an executive body that meets between Assembly sessions.

Programme oversight operates on several timescales. The Assembly approves WHO’s general programme of work, which sets a medium-term strategic direction, and its biennial programme budget, which translates priorities into a financial framework. The Fourteenth General Programme of Work, covering 2025–2028, was approved in 2024. Programme budgets identify intended results across areas such as health-service coverage, emergencies, and healthier populations, alongside the administrative capacities needed to support them. Approval does not itself guarantee that all resources will be received or that all planned activities can be implemented at the same rate.

WHO financing combines assessed contributions and voluntary contributions. Assessed contributions are obligations of Member States under an agreed scale, broadly related to economic capacity and population through the assessment methodology. Voluntary contributions come from governments and other eligible contributors and may be flexible or earmarked for specified purposes. This distinction is central to Assembly governance: delegates may approve a broad programme, but heavily earmarked funding can limit the Secretariat’s ability to move resources between priorities. Budget authorization, cash received, and expenditure are therefore different quantities, and comparisons between budget periods must account for the components included.

The Assembly has addressed this structural issue through financing reforms. In 2022 it agreed to a trajectory intended to raise assessed contributions to 50% of the approved 2022–2023 base budget by the 2030–2031 biennium, subject to the agreed conditions and review processes. In 2023 it approved a 20% increase in assessed contributions for 2024–2025. These decisions concern the balance and predictability of WHO financing rather than the creation of an independent global taxing power. The Assembly also reviews financial statements, audit findings, and administrative reports. Its oversight thus links policy ambitions to the practical questions of who pays, how resources may be used, and how the Secretariat accounts for expenditure.

Disease-control programmes and population health priorities

One of the Assembly’s most consequential roles has been to authorize and sustain coordinated disease-control programmes. In 1958 it adopted a resolution calling for worldwide smallpox eradication, following a proposal advanced by the Soviet Union. In 1966 it approved the intensified eradication programme that began in 1967. The operational approach combined vaccination with increasingly effective surveillance, case investigation, and containment of outbreaks. In 1980, following international certification, the Thirty-third World Health Assembly declared smallpox eradicated. The achievement depended on national health workers, laboratories, international coordination, and sustained financing; the Assembly supplied political authorization and a forum for collective commitment rather than conducting field operations itself.

In 1988 the Assembly committed to the global eradication of poliomyelitis, helping establish the policy basis for the Global Polio Eradication Initiative. This programme brought WHO together with national governments and partner organizations in large-scale vaccination and surveillance efforts. Unlike smallpox, poliovirus presented challenges including extensive asymptomatic transmission and, in some settings, the circulation of vaccine-derived viruses. The contrast demonstrates an important limit of Assembly target-setting: a resolution can establish a common goal and mobilize resources, but the feasibility and timetable of achieving it depend on pathogen biology, delivery systems, security conditions, and community access.

The Assembly has also set strategies for diseases requiring sustained control rather than a single eradication endpoint. In 2014 it endorsed the End TB Strategy, with targets extending to 2035 and with attention to patient-centred care, supportive policies, and research. Its work on tuberculosis, malaria, and HIV/AIDS has repeatedly linked technical interventions to health-service capacity and access to medicines. In 2015 it adopted the Global Action Plan on Antimicrobial Resistance, organized around awareness, surveillance and research, infection prevention, appropriate antimicrobial use, and sustainable investment. These strategies create shared frameworks, but national implementation and the collection of comparable data remain essential to assessing progress.

The agenda also encompasses noncommunicable diseases and their risk factors. The Global Strategy to Reduce the Harmful Use of Alcohol was endorsed in 2010, and the Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013–2020 was adopted in 2013. A 2012 comprehensive implementation plan addressed maternal, infant, and young-child nutrition, including targets concerning stunting, anaemia, low birth weight, childhood overweight, breastfeeding, and wasting. Such instruments demonstrate how the Assembly works beyond epidemic response: it selects measurable priorities and promotes coordinated action across health services, food systems, education, and other sectors without directly administering those sectors within Member States.

Health systems, classifications, and technical standards

The Assembly’s influence extends to the organization of care and the common technical language used by health institutions. Its support for primary health care and universal health coverage concerns whether people can obtain needed services without financial hardship. These concepts involve the design of service delivery, the health workforce, medicines, information systems, and health financing. Assembly resolutions can establish common goals and request WHO guidance, but they do not prescribe a single institutional model for every country. Tax-funded services, social health insurance, and mixed arrangements remain matters of national policy within different economic and constitutional settings.

The adoption of health classifications is a particularly concrete form of standard-setting. In 1948 the First Assembly adopted the sixth revision of the International Classification of Diseases (ICD), expanding the classification’s role in morbidity as well as mortality statistics. In 2019 the Assembly adopted the eleventh revision, ICD-11, which came into effect on 1 January 2022, subject to transitional arrangements. A common classification allows countries to code and aggregate diagnoses and causes of death in a more comparable form. It does not make underlying health records equally complete, nor does its international effective date mean that every country switches systems immediately.

Other classifications address dimensions of health not captured by disease labels alone. The International Classification of Functioning, Disability and Health, endorsed by the Assembly in 2001, describes functioning and disability in relation to bodily functions and structures, activities, participation, and environmental factors. Its framework supports the collection of information about how health conditions affect people’s lives. This differs from identifying a disease or recording its underlying cause of death. The Assembly’s role is to endorse an international standard; its practical use depends on translation into statistical systems, professional training, assessment tools, and national administrative requirements.

Standards concerning medicines and patient care follow a related but not identical pathway. WHO’s first Model List of Essential Medicines appeared in 1977 through expert work, while Assembly decisions have provided policy support for essential-medicines programmes and rational medicine use. The Assembly does not individually approve every medicine on WHO lists or act as a global drug-licensing authority. In patient safety, its 2019 resolution supported global action and established World Patient Safety Day on 17 September; in 2021 it adopted the Global Patient Safety Action Plan 2021–2030. These examples illustrate the division between intergovernmental endorsement, expert technical development, national regulation, and implementation in hospitals and other care settings.

Health emergencies, accountability, and institutional limits

International health emergencies bring the Assembly’s policy role into close contact with legal and operational mechanisms located elsewhere in WHO. Under the International Health Regulations, the Director-General determines whether an event constitutes a public health emergency of international concern, taking account of the required information and advice, including that of an Emergency Committee. The Assembly does not vote on each such determination. Likewise, emergency deployment, technical advice, and coordination with affected countries are generally Secretariat functions. Confusing these roles can obscure responsibility: the Assembly establishes frameworks and scrutinizes performance, while particular emergency decisions follow their own rules.

The COVID-19 crisis prompted several major Assembly actions. In May 2020 the Seventy-third Assembly adopted resolution WHA73.1 on the COVID-19 response, calling for international cooperation and an impartial, independent, and comprehensive evaluation of the international response. The session initially met virtually, illustrating how the emergency altered the institution’s own working methods. The Independent Panel for Pandemic Preparedness and Response subsequently reported to the Assembly in 2021. Its work formed part of a broader examination of preparedness, early warning, coordination, and access to medical countermeasures; it was not a court proceeding assigning legal liability.

At its second special session, held from 29 November to 1 December 2021, the Assembly established an intergovernmental negotiating body to draft and negotiate a convention, agreement, or other international instrument on pandemic prevention, preparedness, and response. This process led to the adoption of the WHO Pandemic Agreement in 2025. Separately, Member States negotiated amendments to the International Health Regulations, adopted in 2024. The two tracks addressed overlapping concerns but used different legal foundations. Their development illustrates the Assembly’s capacity to create negotiating mandates and adopt instruments, as well as the time needed to reconcile positions on financing, information sharing, access to health products, and national responsibilities.

The Assembly’s effectiveness ultimately depends on the relationship between international commitments and domestic capacity. It cannot normally compel governments to fund health services, disclose every relevant piece of information, or implement a recommended intervention. Reporting requirements, public scrutiny, treaty procedures, budget decisions, and repeated review provide mechanisms of accountability, but they are not equivalent to a general enforcement authority. National sovereignty, unequal resources, and the distribution of responsibilities among WHO, other international organizations, and governments shape what its decisions can accomplish. Assessing a particular resolution therefore requires attention not only to its stated objective, but also to its legal basis, financing, implementation arrangements, indicators, and provisions for subsequent reporting.